Pharmaceutical Good Manufacturing Practice Regulations Article 44
Chinese herbal medicine factories shall test every batch of products to ensure that they are in compliance with established specifications; each batch of products that must not contain harmful microorganisms shall, where necessary, be subjected to appropriate tests.Representative samples shall be removed from each batch of products or end products, and taken from the raw materials containing active ingredients used in making aforesaid products, and placed in reserve; aforesaid reserve samples shall be stored under indicated conditions, and shall be of at least twice the quantity needed for all required tests.Reserve samples shall be retained until one year after the expiration date of the product from which it was taken; reserve samples of products that do not require expiration dates shall be kept for at least three years after the date of dispatch of the last batch of aforesaid product.
中文原文 藥物優良製造準則第44條
中藥廠應檢驗每一批產品,確定其符合既定規格;對於不得含有害微生物之產品,必要時並應逐批作適當相關檢驗。
每批產品或最終產品及其各有效成分之原料,應抽取代表性之儲備樣品保存;其儲備樣品之存放條件,應與標示者相同,儲備數量應為足供所有規定檢驗所需要之二倍以上。
儲備樣品,應保存至該產品有效期間屆滿後一年。
但免於標示有效期間之儲備樣品,應至少保存至該產品或最終產品之最後一批出廠後三年。
每批產品或最終產品及其各有效成分之原料,應抽取代表性之儲備樣品保存;其儲備樣品之存放條件,應與標示者相同,儲備數量應為足供所有規定檢驗所需要之二倍以上。
儲備樣品,應保存至該產品有效期間屆滿後一年。
但免於標示有效期間之儲備樣品,應至少保存至該產品或最終產品之最後一批出廠後三年。